Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 6/7/10 AVI BioPharma Discloses New Contract With U.S. Government for up to $18 Million to Advance Development of AVI-7100 as H1N1 Flu Therapeutic 6/3/10 AVI BioPharma to Present at the Jefferies 2010 Global Life Sciences Conference 5/11/10 AVI BioPharma to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference 5/10/10 AVI BioPharma Announces First Quarter 2010 Financial Results 5/7/10 AVI BioPharma and Collaborators Publish Data From Preclinical Studies Demonstrating the Antimicrobial Efficacy of PMO Oligomers Against Burkholderia Cepacia Complex in The Journal of Infectious Diseases 5/3/10 AVI BioPharma Announces First Quarter 2010 Financial Results and Corporate Update Conference Call 4/28/10 AVI BioPharma Secures Increased Funding of Approximately $4.0 Million Under Its Contract With the U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu 4/21/10 AVI BioPharma Appoints David Boyle Interim President and CEO 3/26/10 AVI BioPharma Issues Statement Regarding Filing by Shareholder Group 3/25/10 AVI BioPharma Announces Update on AVI-5038, Its PPMO Duchenne Muscular Dystrophy Drug Candidate, to Be Presented April 14, 2010 at the American Academy of Neurology Annual Meeting Pagination First page « first Previous page ‹ previous … Page 60 Page 61 Page 62 Page 63 Current page 64 Page 65 Page 66 Page 67 Page 68 … Next page next › Last page last » Displaying 631 - 640 of 816 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 6/7/10 AVI BioPharma Discloses New Contract With U.S. Government for up to $18 Million to Advance Development of AVI-7100 as H1N1 Flu Therapeutic 6/3/10 AVI BioPharma to Present at the Jefferies 2010 Global Life Sciences Conference 5/11/10 AVI BioPharma to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference 5/10/10 AVI BioPharma Announces First Quarter 2010 Financial Results 5/7/10 AVI BioPharma and Collaborators Publish Data From Preclinical Studies Demonstrating the Antimicrobial Efficacy of PMO Oligomers Against Burkholderia Cepacia Complex in The Journal of Infectious Diseases 5/3/10 AVI BioPharma Announces First Quarter 2010 Financial Results and Corporate Update Conference Call 4/28/10 AVI BioPharma Secures Increased Funding of Approximately $4.0 Million Under Its Contract With the U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu 4/21/10 AVI BioPharma Appoints David Boyle Interim President and CEO 3/26/10 AVI BioPharma Issues Statement Regarding Filing by Shareholder Group 3/25/10 AVI BioPharma Announces Update on AVI-5038, Its PPMO Duchenne Muscular Dystrophy Drug Candidate, to Be Presented April 14, 2010 at the American Academy of Neurology Annual Meeting Pagination First page « first Previous page ‹ previous … Page 60 Page 61 Page 62 Page 63 Current page 64 Page 65 Page 66 Page 67 Page 68 … Next page next › Last page last » Displaying 631 - 640 of 816